Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Trying to decide which is better: cash back or points credit cards? Analyze your spending habits to make the best choice for maximizing rewards.
27,088 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Greg Abel is stepping into a part of the market Warren Buffett mostly left untouched. This article breaks down what A...
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Oil prices cooled after news that wealthy nations may coordinate an emergency reserve release. Analysts warn that pri...
Nebius’s stock surges latest after the company lands a Meta partnership valued at up to $27 billion, building on a re...
Veteran investor Mark Kvamme is rolling out a Temasek style OHIO Fund, a $500 million vehicle aimed at accelerating g...
A high-stakes clash between Ray Dalio and Michael Saylor drives a renewed bitcoin price analysis as markets digest Bi...
May wholesale prices rose again for the second straight month, marking the largest back-to-back gain since 2022 and s...
A crypto strategist argues that a signed U.S.-Iran peace deal could unleash a rapid rally in risk assets, with crypto...
Swsh, a college photo-sharing app, pivots from campus albums to an AI-powered data engine that markets fan content to...
San Francisco-based Framework Ventures closes its fourth fund at $400 million, expanding beyond crypto into frontier ...
Rocket Lab stock surged on upbeat results and new contracts, signaling renewed investor interest. This guide breaks d...